Combined approach enhances radiotherapy

Combining external-beam radiotherapy (EBRT) with internal irradiation via radioimmunotherapy (RIT) holds promise of a significantly potent cancer treatment. EBRT delivers precise, high radiation doses to a solid tumour, while RIT can boost the dose to the primary disease site and deliver radiation to tumour cells located beyond the EBRT field.